Abstract:BACKGROUND:Translocation of high-mobility group box 1 (HMGB1) from nucleus could trigger inflammation. Extracellular HMGB1 up-regulates inflammatory response in sepsis as a late mediator. However, little was known about its role in subarachnoid hemorrhage-inducible inflammation, especially in the early stage. This study aims to identify whether HMGB1 translocation occurred early after SAH and also to clarify the potential role of HMGB1 in brain injury following SAH.METHODS:Sprague-Dawley (SD) rats were randomly divided into sham group and SAH groups at 2 h, 12 h and on day 1, day 2. SAH groups suffered experimental subarachnoid hemorrhage by injection of 0.3 ml autoblood into the pre-chiasmatic cistern. Rats injected by recombinant HMGB1(rHMGB1) solution were divided into four groups according to different time points. Cultured neurons were assigned into control group and four hemoglobin (Hb) incubated groups. Mixed glial cells were cultured and stimulated in medium from neurons incubated by Hb. HMGB1 expression is measured by western blot analysis, real-time polymerase chain reaction (PCR), immunohistochemistry and immunofluorescence. Downstream nuclear factor kappa B (NF-κB) subunit P65 and inflammatory factor Interleukin 1β (IL-1β) were measured by western blot and real-time PCR, respectively. Brain injury was evaluated by cleaved caspase-3 staining.RESULTS:Our results demonstrated HMGB1 translocation occurred as early as 2 h after experimental SAH with mRNA and protein level increased. Immunohistochemistry and immunofluorescence results indicated cytosolic HMGB1 was mainly located in neurons while translocated HMGB1 could also be found in some microglia. After subarachnoid injection of rHMGB1, NF-κB, downstream inflammatory response and cleaved caspase-3 were up-regulated in the cortex compared to the saline control group. In-vitro, after Hb incubation, HMGB1 was also rapidly released from neurons to medium. Incubation with medium from neurons up-regulated IL-1β in mixed glial cells. This effect could be inhibited by HMGB1 specific inhibitor glycyrrhizic acid (GA) treatment.CONCLUSION:HMGB1 was released from neurons early after SAH onset and might trigger inflammation as an upstream inflammatory mediator. Extracellular HMGB1 contributed to the brain injury after SAH. These results might have important implications during the administration of specific HMGB1 antagonists early in order to prevent or reduce inflammatory response following SAH.

Early Antagonism of Cerebral High Mobility Group Box-1 Protein is Benefit for Sepsis Induced Brain Injury.

Inhibition of Cerebral High-Mobility Group Box 1 Protein Attenuates Multiple Organ Damage and Improves T Cell-Mediated Immunity in Septic Rats

Antagonism of Cerebral High Mobility Group Box 1 Ameliorates Dendritic Cell Dysfunction in Sepsis

Role of HMGB1 Translocation to Neuronal Nucleus in Rat Model with Septic Brain Injury.

HMGB1 Mediates Synaptic Loss and Cognitive Impairment in an Animal Model of Sepsis-Associated Encephalopathy

Early accumulation of high-mobility group box 1 protein in penumbra region of the brain following transient middle cerebral arterial occlusion in the rat

Severity of Sepsis is Correlated with the Elevation of Serum High-Mobility Group Box 1 in Rats.

Novel Insights For High Mobility Group Box 1 Protein-Mediated Cellular Immune Response In Sepsis: A Systemic Review

Early Release of High-Mobility Group Box 1 (HMGB1) from Neurons in Experimental Subarachnoid Hemorrhage in Vivo and in Vitro.

High-mobility Group Box1 Protein Promotes Neuroinflammation after Intracerebral Hemorrhage in Rats

High Mobility Group Protein 1 Reverses Immune System Paralysis in Late-Phase Sepsis

[Advances in high mobility group box-1 protein mediated multiple organ dysfunction and its potential interventional strategies].

The Roles of High Mobility Group Box 1 in Cerebral Ischemic Injury

Targeting HMGB1 for the treatment of sepsis and sepsis-induced organ injury

High-Mobility Group Box 1 in Spinal Cord Injury and Its Potential Role in Brain Functional Remodeling After Spinal Cord Injury

HMGB1 promotes neurovascular remodeling via Rage in the late phase of subarachnoid hemorrhage

Inflammatory Response and Immune Regulation of High Mobility Group Box-1 Protein in Treatment of Sepsis.

Therapeutic targeting of HMGB1 during experimental sepsis modulates the inflammatory cytokine profile to one associated with improved clinical outcomes

The Role of High Mobility Group Box 1 in Ischemic Stroke

High Plasma Levels of High Mobility Group Box 1 is Associated with the Risk of Sepsis in Severe Blunt Chest Trauma Patients: a Prospective Cohort Study

High Mobility Group Box-1 (HMGB1), a Key Mediator of Cognitive Decline in Neurotrauma with a Potential for Targeted Therapy: A Comprehensive Review